| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |